Ivan H. El-Sayed
Expertise in
22
conditions
Expertise in
22
conditions
1825 Fourth St., Fifth Floor, 
San Francisco, CA 

Overview

Dr. Ivan H. El-Sayed is a head and neck cancer surgeon. He specializes in treating benign and malignant lesions of the salivary glands, paranasal sinuses and skull base. El-Sayed's research interests include examining the value of sentinel node biopsy (a procedure to check whether cancer has spread) for head and neck cancer. He also is investigating potential uses of lasers and nanoparticles for diagnosing and treating cancer. El-Sayed earned his medical degree and completed a residency in otolaryngology at Boston University School of Medicine. He completed a fellowship in head and neck oncology at UCSF.

Dr. El-Sayed is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Turbinectomy.

Dr. El-Sayed is board certified in American Board Of Otolaryngology, Otolaryngology. He is actively involved in clinical research, co-authoring 143 peer reviewed articles. Dr. El-Sayed is currently accepting new patients.

Specialties

Otolaryngology

Licenses

Otolaryngology in CA

Board Certifications

American Board Of Otolaryngology, Otolaryngology

Fellowships

UCSF Graduate Medical Education, Otolaryngology

Hospital Affiliations

Providence Santa Rosa Memorial Hospital
Ucsf Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 7 Less Insurance Carriers -

Locations

Head and Neck Surgery Cancer Program
1825 Fourth St., Fifth Floor, San Francisco, CA 94158
Other Locations
Sinus Center
2380 Sutter St., Third Floor, San Francisco, CA 94115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Similar Doctors
Expertise in
20
conditions
Otolaryngology
Expertise in
20
conditions
Otolaryngology
Referral may be required

Oral Dysplasia Program

1825 Fourth St., Fifth Floor, 
San Francisco, CA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Patrick Ha is chief of the UCSF Division of Head and Neck Surgical Oncology. His expertise in patient care covers the full scope of head and neck surgery, with a focus on thyroid and parathyroid surgery as well as endoscopic approaches to throat cancer surgery. Ha's research is currently focused on molecular changes that occur in adenoid cystic carcinoma of the salivary gland. Ha received an undergraduate degree in biology from Harvard University, graduating magna cum laude. He obtained his medical degree from Johns Hopkins School of Medicine, graduating with membership in the Alpha Omega Alpha Honor Medical Society. He then completed his residency training and a postdoctoral fellowship at the otolaryngology department of Johns Hopkins, along with advanced fellowship training in head and neck oncologic surgery. Ha serves on the editorial board of several medical journals, including Oral Oncology. He is the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer. Dr. Ha is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Ha is board certified in American Board Of Otolaryngology, Otolaryngology. Dr. Ha is currently accepting new patients.

Expertise in
21
conditions
Otolaryngology
Expertise in
21
conditions
Otolaryngology
Referral may be required

Head And Neck Medical Oncology Program

1825 Fourth St., Fifth Floor, 
San Francisco, CA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Laryngeal Cancer. Dr. Algazi is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Algazi is currently accepting new patients.

Expertise in
30
conditions
Otolaryngology
Expertise in
30
conditions
Otolaryngology
Referral may be required

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (25.9 miles away)
Languages Spoken:
English
Offers Telehealth

Peter Hwang is an Otolaryngologist practicing medicine in Stanford, California. Dr. Hwang is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Septoplasty, and Endoscopy.

Frequently Asked Questions about Dr. Ivan H. El-Sayed

How do I make an appointment with Dr. Ivan H. El-Sayed?

You can book an appointment with Dr. Ivan H. El-Sayed by calling their office at 415-885-7528. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ivan H. El-Sayed a top-rated expert for Olfactory Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ivan H. El-Sayed is classified as an Elite expert for Olfactory Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ivan H. El-Sayed specialize in?

While Dr. Ivan H. El-Sayed is a Otolaryngology, they have specific expertise in Olfactory Neuroblastoma, Sinus Cancer, and Teratocarcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Otolaryngology.

Does Dr. Ivan H. El-Sayed participate in research or clinical trials?

Yes. Dr. Ivan H. El-Sayed has published 143 articles and abstracts on conditions like Olfactory Neuroblastoma. You can view a list of Dr. Ivan H. El-Sayed's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ivan H. El-Sayed accept my insurance?

Dr. Ivan H. El-Sayed accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-885-7528 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. El-Sayed's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile